421 related articles for article (PubMed ID: 28553945)
1. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
[TBL] [Abstract][Full Text] [Related]
2. Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B.
Bailey J; Douglas H; Masino L; de Carvalho LPS; Argyrou A
Biochemistry; 2021 Nov; 60(47):3621-3632. PubMed ID: 34780697
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach.
Gao F; Ding X; Cao Z; Zhu W; Fan Y; Steurer B; Wang H; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
Bioorg Med Chem; 2024 Feb; 100():117633. PubMed ID: 38342078
[TBL] [Abstract][Full Text] [Related]
5. Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy.
Guo J; Yang Y; Buettner R; Rosen ST
Curr Opin Oncol; 2022 Sep; 34(5):546-551. PubMed ID: 35788128
[TBL] [Abstract][Full Text] [Related]
6. Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors.
Li C; Gui G; Zhang L; Qin A; Zhou C; Zha X
J Med Chem; 2022 Jul; 65(14):9531-9547. PubMed ID: 35796517
[TBL] [Abstract][Full Text] [Related]
7. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
8. Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous
Konteatis Z; Travins J; Gross S; Marjon K; Barnett A; Mandley E; Nicolay B; Nagaraja R; Chen Y; Sun Y; Liu Z; Yu J; Ye Z; Jiang F; Wei W; Fang C; Gao Y; Kalev P; Hyer ML; DeLaBarre B; Jin L; Padyana AK; Dang L; Murtie J; Biller SA; Sui Z; Marks KM
J Med Chem; 2021 Apr; 64(8):4430-4449. PubMed ID: 33829783
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
Strekalova E; Malin D; Weisenhorn EMM; Russell JD; Hoelper D; Jain A; Coon JJ; Lewis PW; Cryns VL
Breast Cancer Res Treat; 2019 May; 175(1):39-50. PubMed ID: 30712196
[TBL] [Abstract][Full Text] [Related]
10. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
[TBL] [Abstract][Full Text] [Related]
11. Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits.
Shafqat N; Muniz JR; Pilka ES; Papagrigoriou E; von Delft F; Oppermann U; Yue WW
Biochem J; 2013 May; 452(1):27-36. PubMed ID: 23425511
[TBL] [Abstract][Full Text] [Related]
12. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.
Tomasi ML; Ryoo M; Skay A; Tomasi I; Giordano P; Mato JM; Lu SC
Exp Cell Res; 2013 Jul; 319(12):1902-1911. PubMed ID: 23588207
[TBL] [Abstract][Full Text] [Related]
13. Fragment-Based Design of a Potent MAT2a Inhibitor and
De Fusco C; Schimpl M; Börjesson U; Cheung T; Collie I; Evans L; Narasimhan P; Stubbs C; Vazquez-Chantada M; Wagner DJ; Grondine M; Sanders MG; Tentarelli S; Underwood E; Argyrou A; Smith JM; Lynch JT; Chiarparin E; Robb G; Bagal SK; Scott JS
J Med Chem; 2021 May; 64(10):6814-6826. PubMed ID: 33900758
[TBL] [Abstract][Full Text] [Related]
14. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
[TBL] [Abstract][Full Text] [Related]
15. mTORC1-independent translation control in mammalian cells by methionine adenosyltransferase 2A and S-adenosylmethionine.
Alam M; Shima H; Matsuo Y; Long NC; Matsumoto M; Ishii Y; Sato N; Sugiyama T; Nobuta R; Hashimoto S; Liu L; Kaneko MK; Kato Y; Inada T; Igarashi K
J Biol Chem; 2022 Jul; 298(7):102084. PubMed ID: 35636512
[TBL] [Abstract][Full Text] [Related]
16. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.
Nordgren KK; Peng Y; Pelleymounter LL; Moon I; Abo R; Feng Q; Eckloff B; Yee VC; Wieben E; Weinshilboum RM
Drug Metab Dispos; 2011 Nov; 39(11):2135-47. PubMed ID: 21813468
[TBL] [Abstract][Full Text] [Related]
17. Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo.
Wang YC; Chiang EP
Mol Med; 2012 May; 18(1):423-32. PubMed ID: 22193356
[TBL] [Abstract][Full Text] [Related]
18. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
Yang H; Huang ZZ; Zeng Z; Chen C; Selby RR; Lu SC
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G184-90. PubMed ID: 11208539
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
Lo TF; Tsai WC; Chen ST
PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
[TBL] [Abstract][Full Text] [Related]
20. 8-Cl-Ado and 8-NH
Guo J; Buettner R; Du L; Li Z; Liu W; Su R; Chen Z; Che Y; Zhang Y; Ma R; Nguyen LXT; Moore RE; Khyatiben P; Chen MH; Patrick P; Wu X; Marcucci G; Wang L; Horne D; Chen J; Yang Y; Rosen ST
Leukemia; 2024 Jun; 38(6):1236-1245. PubMed ID: 38643304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
